imatinib mesylate has been researched along with Myelodysplastic-Myeloproliferative Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cross, NC; Erben, P; Gosenca, D; Haferlach, C; Hänel, A; Hochhaus, A; Metzgeroth, G; Reiter, A; Walz, C | 1 |
1 other study(ies) available for imatinib mesylate and Myelodysplastic-Myeloproliferative Diseases
Article | Year |
---|---|
Identification of a MYO18A-PDGFRB fusion gene in an eosinophilia-associated atypical myeloproliferative neoplasm with a t(5;17)(q33-34;q11.2).
Topics: Antineoplastic Agents; Benzamides; Chromosome Painting; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 5; Eosinophilia; Gene Fusion; Humans; Imatinib Mesylate; Male; Middle Aged; Mutant Chimeric Proteins; Myelodysplastic-Myeloproliferative Diseases; Myosins; Piperazines; Polymerase Chain Reaction; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; Translocation, Genetic | 2009 |